Description:

CALGB: 49808 RESPONSE/PROGRESSION FORM NCT00016276 Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9E35395C-867B-227A-E034-080020C9C0E0

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9E35395C-867B-227A-E034-080020C9C0E0

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 5/22/15
  3. 6/3/15
Uploaded on:

June 3, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

CALGB: 49808 RESPONSE/PROGRESSION FORM NCT00016276

No Instruction available.

  1. StudyEvent: CALGB: 49808 RESPONSE/PROGRESSION FORM
    1. No Instruction available.
CALGB clinical trial administrative data
Amended data?
Patient clinical trial data
Response Assessment (clinical/radiographic)
Has the patient achieved a response (not previously reported)?
Has the patient been diagnosed with a new progression during this reporting period (not previously reported)?
Has the patient been diagnosed with a new local-regional recurrence since submission of the last follow-up form? (IF YES:)
Site(s) of First Local-Regional Recurrence (mark all that apply with an X)
How was this recurrence information obtained?
Has the patient been diagnosed with a first distant progression since submission of the last follow-up form? (IF YES, continued)
How was this progression information obtained?
Comments